His primary areas of study are Cancer research, Radiation therapy, Pathology, Immunology and Apoptosis. His Cancer research research is multidisciplinary, relying on both Paclitaxel, Chemotherapy, Ratón, Radioresistance and Receptor. His Radiation therapy research integrates issues from Cell cycle, Cancer and In vivo.
The concepts of his Pathology study are interwoven with issues in Tumor necrosis factor alpha, Cell culture, Epidermal growth factor, Radiosensitivity and Epidermal growth factor receptor. His work carried out in the field of Immunology brings together such families of science as Clinical trial, Animal studies and Therapeutic index. He combines subjects such as Endocrinology and Oncology with his study of Internal medicine.
Luka Milas mostly deals with Cancer research, Radiation therapy, Pathology, Internal medicine and Chemotherapy. His work deals with themes such as Radiosensitivity, Apoptosis, Paclitaxel, Immunology and In vivo, which intersect with Cancer research. His Radiation therapy research is multidisciplinary, incorporating perspectives in Cancer, Epidermal growth factor receptor, Clinical trial, Therapeutic index and Pharmacology.
He has researched Pathology in several fields, including Lung and Ratón. His research investigates the connection with Internal medicine and areas like Oncology which intersect with concerns in Head and neck cancer. His Chemotherapy research incorporates elements of Angiogenesis and Immunotherapy.
The scientist’s investigation covers issues in Cancer research, Radiation therapy, Cancer, Radiosensitivity and Internal medicine. His Cancer research study combines topics in areas such as Epidermal growth factor receptor, Head and neck squamous-cell carcinoma, Immunology, Pathology and Radioresistance. His Radiation therapy study integrates concerns from other disciplines, such as Tumor bed, Clinical trial, Cancer stem cell, Tumor growth and Carcinoma.
His Cancer research includes elements of Poly ADP ribose polymerase, Poly Polymerase Inhibitor, Stem cell and In vivo. His research in Radiosensitivity intersects with topics in Cell, Cell cycle, Apoptosis, Cell culture and DNA repair. His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
Luka Milas focuses on Cancer research, DNA repair, Cancer cell, Radiosensitivity and Cancer. His biological study spans a wide range of topics, including In vivo, DNA damage and Epidermal growth factor receptor. His DNA repair research is multidisciplinary, incorporating elements of Cell and Cell biology.
His Radiosensitivity research incorporates themes from Clonogenic assay and Pathology. His research integrates issues of Radiation therapy and Programmed cell death in his study of Cancer stem cell. His study in Radiation therapy is interdisciplinary in nature, drawing from both Clinical trial, Immunology and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
K. Kian Ang;Brian A. Berkey;Xiaoyu Tu;Hua Zhong Zhang.
Cancer Research (2002)
Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase
Klaus Dittmann;Claus Mayer;Birgit Fehrenbacher;Martin Schaller.
Journal of Biological Chemistry (2005)
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Luka Milas;Kathy Mason;Nancy Hunter;Sven Petersen.
Clinical Cancer Research (2000)
Complete Regression of Well-established Tumors Using a Novel Water-soluble Poly(l-Glutamic Acid)-Paclitaxel Conjugate
Chun Li;Dong Fang Yu;Robert A. Newman;Fernando Cabral.
Cancer Research (1998)
Inverse Relationship between Epidermal Growth Factor Receptor Expression and Radiocurability of Murine Carcinomas
Tetsuo Akimoto;Nancy R. Hunter;Lara Buchmiller;Kathy Mason.
Clinical Cancer Research (1999)
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
Kazushi Kishi;Sven Petersen;Cordula Petersen;Nancy Hunter.
Cancer Research (2000)
The epidermal growth factor receptor mediates radioresistance.
Ke Liang;K.Kian Ang;Luka Milas;Nancy Hunter.
International Journal of Radiation Oncology Biology Physics (2003)
Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme
Luka Milas;Kazushi Kishi;Nancy Hunter;Kathryn Mason.
Journal of the National Cancer Institute (1999)
Sensitization of breast cancer cells to radiation by trastuzumab.
Ke Liang;Yang Lu;Weidong Jin;K. Kian Ang.
Molecular Cancer Therapeutics (2003)
Apoptosis in irradiated murine tumors.
L. C. Stephens;K. K. Ang;T. E. Schultheiss;L. Milas.
Radiation Research (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: